selected publications
- Follicular lymphoma grade 3B: low grade, high grade or should we skip the grade?. Haematologica. 2023 Academic Article GET IT
-
Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL.
Blood.
2023
Academic Article
GET IT
Times cited: 5 -
Inhibition of Integrin αVβ3 Signaling Improves the Antineoplastic Effect of Bexarotene in Cutaneous T-Cell Lymphoma.
Molecular cancer therapeutics.
2022
Academic Article
GET IT
Times cited: 1 -
Phase 1 study of oral azacitidine (CC-486) plus R-CHOP in previously untreated intermediate- to high-risk DLBCL.
Blood.
2022
Academic Article
GET IT
Times cited: 13 -
Biomarker-driven management strategies for peripheral T cell lymphoma.
Journal of hematology & oncology.
2020
Review
GET IT
Times cited: 18 -
IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas.
PloS one.
2015
Academic Article
GET IT
Times cited: 72